Dec 10 (Reuters) - French biotech company Abivax's (ABVX.PA), opens new tab shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly (LLY.N), opens new tab could make an ...
The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US ...
ORLANDO, Fla.—The leader of Gilead Sciences' Kite Pharma is sure that anito-cel, the biotech’s next-generation multiple myeloma CAR-T challenger to Carvykti, is ready for prime time—and that the ...
SHANGHAI, Dec 5 (Reuters) - China's Sichuan Kelun-Biotech Biopharmaceutical (6990.HK) said Thursday night, opens new tab it would license an experimental cancer treatment out to U.S. drugmaker ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Austin-based Natera is expanding ...
A North Carolina Republican U.S. Senator and a Democrat colleague recently introduced a bill promote U.S. leadership in biotechnology and strengthen domestic biopharmaceutical manufacturing. U.S.
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback